Arbor Trust Wealth Advisors LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Arbor Trust Wealth Advisors LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 30.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,423 shares of the healthcare conglomerate’s stock after buying an additional 569 shares during the quarter. Arbor Trust Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,276,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in UNH. Wellington Management Group LLP increased its position in shares of UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Morgan Stanley increased its holdings in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC increased its holdings in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Alliancebernstein L.P. increased its holdings in UnitedHealth Group by 3.5% in the second quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after buying an additional 399,739 shares during the last quarter. Finally, Norges Bank bought a new stake in UnitedHealth Group in the fourth quarter valued at about $5,210,004,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on UNH shares. Morgan Stanley lowered their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Piper Sandler lowered their target price on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Three equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $573.80.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $23.51 on Tuesday, hitting $469.14. 11,815,185 shares of the company were exchanged, compared to its average volume of 4,407,902. The firm has a market capitalization of $432.51 billion, a price-to-earnings ratio of 19.66, a PEG ratio of 1.20 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company’s 50 day moving average price is $491.15 and its two-hundred day moving average price is $515.88.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.54 by $0.37. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the previous year, the company earned $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.60%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 31.54%.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.